Zsírmáj (MASLD/MASH): vizsgálatok itt: Szaúd-Arábia

5 trials · From ClinicalTrials.gov, checked 2026. november 10.. Ask the study team whether a trial fits you.

• 3. fázisTaking people
  LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

  Where

  Riyadh

  Életkor

  18 év and over

  People

  1800 worldwide

  Run by

  Boehringer Ingelheim

  See details and how to joinNCT06632444 · EU 2024-513739-25-00
• 3. fázisTaking people
  LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

  Where

  Riyadh

  Életkor

  18 év and over

  People

  1590 worldwide

  Run by

  Boehringer Ingelheim

  See details and how to joinNCT06632457 · EU 2024-513741-36-00
• 3. fázisTaking people
  A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH

  Where

  Riyadh

  Életkor

  18 év to 75 év

  People

  1250 worldwide

  Run by

  GlaxoSmithKline

  See details and how to joinNCT07221188 · EU 2025-523674-16-00
• 3. fázisTaking people
  A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

  Where

  Riyadh

  Életkor

  18 év to 75 év

  People

  1200 worldwide

  Run by

  GlaxoSmithKline

  See details and how to joinNCT07221227
• No phaseTaking people
  Non-Alcoholic Fatty Liver Disease in a Saudi Cohort With Type 2 Diabetes Mellitus

  Where

  Riyadh

  Életkor

  18 év to 60 év

  People

  1000

  Run by

  King Saud University

  See details and how to joinNCT05697991